Autres langues Avicanna Inc. OTC Markets

Actions

AVCNF

CA05368K1003

Recherche biotechnologique et médicale

Temps Différé OTC Markets Autres places de cotation 20:42:32 07/08/2026			Varia. 5j.	Varia. 1 janv.
0,0926 ^USD	+1,42%		-0,11%	-42,87%

16/07	Avicanna lance une gamme de cannabis médical à action rapide au Canada	MT
16/07	Avicanna lance Quix, une gamme de cannabis médical à action rapide	CI

Autres langues

16/07	Avicanna Launching Rapid Onset Medical Cannabis Portfolio in Canada
16/07	Avicanna Introduces Quix Rapid-Onset Medical Cannabis Portfolio
16/07	Avicanna Introduces QUIX™ Rapid-Onset Medical Cannabis Portfolio
30/06	Avicanna Announces Promotion of Nick Hilborn CPA CA to Chief Financial Officer
30/06	Avicanna Inc. Promotes Nick Hilborn to Chief Financial Officer, Effective June 30, 2026
15/06	Avicanna Announces Closing of Non-Brokered Private Placement
14/05	Avicanna Swings to Net Comprehensive Loss in Q1
14/05	Earnings Flash (AVCN.TO) Avicanna Reports Q1 Revenue $6.7M, Up 6% YoY and Highest Ever
14/05	Avicanna Reports Q1 2026 Financial Statements
13/05	Avicanna Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026
08/05	Avicanna Announces Results of Annual General and Special Meeting
02/05	Avicanna Announces Change in Board of Directors
02/05	Avicanna Inc. Announces Resignation of Eileen McCormack as A Member of the Board of Directors , Effective May 1, 2026
30/04	Companies with cannabis-based drugs eye IPOs, private funding boost after US reclassification
28/04	Avicanna Welcomes Initial U.S. Rescheduling of Medical Cannabis & Provides Scientific Update
23/04	Instant View: Cannabis rescheduling fuels optimism across industry
21/04	Annual General and Special Meeting of Shareholders to be held May 7, 2026
20/04	Avicanna Announces Agenda for 6th Annual Clinical Symposium on Cannabinoid Therapeutics
08/04	ThreeD Capital Announces Disposition of Securities of Avicanna; Announces Acquisition of Securities of AI/ML Innovations
06/04	Avicanna Announces Changes to its Board of Directors
06/04	Avicanna Inc. Announces Board Changes, Effective April 1, 2026
01/04	Avicanna reports full year 2025 audited financial statements
01/04	Avicanna Brief: Revenue Totaled $6.6M in Q4 2025
01/04	Avicanna Reports Full Year 2025 Audited Financial Statements
01/04	Avicanna Inc. Reports Earnings Results for the Full Year Ended December 31, 2025